|
Loading...
| ||||||||||||||
Recent Publications by Cambridge Antibody Technology Ltd: |  | |
| Healthcare, molecular tools and applied genome research.
Biotechnology 2000 offered a rare opportunity for scientists from academia... | Cambridge Antibody Technology Ltd, The Science Park, Melbourn, Royston, | IDrugs. 2000 Nov;3(11):1302-4. |
| IBC's conference on antibody engineering; new technology, application and commercialisation.
This was the first antibody engineering conference held by IBC Conferences... | Cambridge Antibody Technology Ltd., The Science Park, Melbourn, | Expert Opin Investig Drugs. 1998 May;7(5):835-8.
DOI Direct Link |
| Oxidative signalling and inflammatory pathways in Alzheimer's disease.
It is well established that inflammation and oxidative stress are key... | Cambridge Antibody Technology Ltd., Science Park, Melbourn SG8 6JJ, U.K. | Biochem Soc Symp. 2001;(67):141-9. |
| Improved tumour targeting by disulphide stabilized diabodies expressed in Pichia pastoris.
Diabodies are dimeric antibody fragments held together by associated heavy... | Cambridge Antibody Technology Ltd, Melbourn, Cambridgeshire, UK. | Protein Eng. 1997 Oct;10(10):1221-5. |
| Phage diabody repertoires for selection of large numbers of bispecific antibody fragments.
Methods for the generation of large numbers of different bispecific... | Cambridge Antibody Technology Ltd., Melbourn, Cambridgeshire, UK. | Nat Biotechnol. 1996 Sep;14(9):1149-54.
DOI Direct Link |
Cambridge Antibody Technology Ltd Patents: |  |
| US Patent No. | Title |
| 7368111 | Human antibodies specific for TGF.beta.2 |
| 6342588 | Labelling and selection of molecules |
| 6291650 | Methods for producing members of specific binding pairs |
| 6225447 | Methods for producing members of specific binding pairs |
| 6180336 | Labelling and selection of molecules |